HOUSTON, August 14, 2026--U.S. Physical Therapy, Inc. ("USPH" or the "Company") (NYSE, NYSE Texas: USPH), a national operator of outpatient physical therapy clinics and provider of industrial injury prevention services ("IIP"), today announced that Nchacha Etta will serve as the Company’s Executive Vice President and Chief Financial Officer, effective as of September 1, 2026.
Florida program extends WRAP’s early-intervention, situational-awareness and force-avoidance training principles beyond law enforcement for security market
HONG KONG - August 14, 2026 ( NEWMEDIAWIRE ) - FWD Group Holdings Limited (“FWD Group” or “FWD”) today marked its 13th anniversary by announcing charitable grants dedicated to supporting more than 13,000 people in communities across Asia. Established in 2013 with a mission to move the life insurance industry in a new direction, FWD Group has grown from its early operations in Hong Kong SAR, Macau SAR and Thailand into a pan-Asian life and health insurer serving millions of customers and their families across 10 markets. In July last year, FWD Group reached another milestone with its listing on the Hong Kong Stock Exchange, under the stock code 1828. Huynh Thanh Phong, Group Chief Executive Officer and Executive Director of FWD Group, said, “At FWD Group, changing the way people feel about
- Appointed Michael Halstead, former President of Intra-Cellular Therapies, as Chief Executive Officer to lead Helus Pharma through late-stage development and commercialization -
(PR-inside.com) NEW YORK, NY / ACCESS Newswire / August 14, 2026 / Levi & Korsinsky, LLP announces that a securities class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Capricor Therapeutics, Inc. (NASDAQ:CAPR) securities. If you suffered a loss on your Capricor Therapeutics, Inc. investment and would like to explore a potential recovery under the federal securities laws, Learn about Capricor Therapeutics, Inc. Class Action or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call (212)363-7500 to speak to our team of experienced shareholder advocates. THE LAWSUIT: A class action securities lawsuit was filed against ..
(PR-inside.com) NEW YORK, NY / ACCESS Newswire / August 14, 2026 / Levi & Korsinsky, LLP announces that a securities class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Rackspace Technology, Inc. (NASDAQ:RXT) securities. If you suffered a loss on your Rackspace Technology, Inc. investment and would like to explore a potential recovery under the federal securities laws, Learn about Rackspace Technology, Inc. Class Action or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call (212)363-7500 to speak to our team of experienced shareholder advocates. THE LAWSUIT: A class action securities lawsuit was filed against ..
(PR-inside.com) NEW YORK, NY / ACCESS Newswire / August 14, 2026 / Levi & Korsinsky, LLP announces that a securities class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired iTonic Holdings Ltd. f/k/a Pheton Holdings Ltd. (NASDAQ:ITOC) securities. If you suffered a loss on your iTonic Holdings Ltd. f/k/a Pheton Holdings Ltd. investment and would like to explore a potential recovery under the federal securities laws, Learn about iTonic Holdings Ltd. f/k/a Pheton Holdings Ltd. Class Action or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call (212)363-7500 to speak to our team of ..
(PR-inside.com) NEW YORK, NY / ACCESS Newswire / August 14, 2026 / Levi & Korsinsky, LLP announces that a securities class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) securities. If you suffered a loss on your Regeneron investment and would like to explore a potential recovery under the federal securities laws, Learn about Regeneron Class Action or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call (212)363-7500 to speak to our team of experienced shareholder advocates. THE LAWSUIT: A class action securities lawsuit was filed against Regeneron Pharmaceuticals, Inc. that ..
(PR-inside.com) NEW YORK, NY / ACCESS Newswire / August 14, 2026 / Levi & Korsinsky, LLP announces that a securities class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Peabody Energy Corporation (NYSE:BTU) securities. If you suffered a loss on your Peabody Energy investment and would like to explore a potential recovery under the federal securities laws, Learn about Peabody Energy Class Action or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call (212)363-7500 to speak to our team of experienced shareholder advocates. THE LAWSUIT: A class action securities lawsuit was filed against Peabody Energy ..
(PR-inside.com) NEW YORK, NY / ACCESS Newswire / August 14, 2026 / Levi & Korsinsky, LLP announces that a securities class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Megan Holdings Limited (NASDAQ:MGN) securities. If you suffered a loss on your Megan investment and would like to explore a potential recovery under the federal securities laws, Learn about Megan Class Action or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call (212)363-7500 to speak to our team of experienced shareholder advocates. THE LAWSUIT: This lawsuit is on behalf of persons and entities that purchased or ..
(PR-inside.com) NEW YORK, NY / ACCESS Newswire / August 14, 2026 / Levi & Korsinsky, LLP announces that a securities class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Hub Group, Inc. (NASDAQ:HUBG) securities. If you suffered a loss on your Hub Group, Inc. investment and would like to explore a potential recovery under the federal securities laws, Learn about Hub Group, Inc. Class Action or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call (212)363-7500 to speak to our team of experienced shareholder advocates. THE LAWSUIT: A class action securities lawsuit was filed against ..
(PR-inside.com) BOSTON, MA / ACCESS Newswire / August 14, 2026 / Block & Leviton is investigating Cellebrite DI (Nasdaq:CLBT) for potential securities law violations. Investors who have lost money in their Cellebrite DI investment should contact the firm to learn more about how they might recover those losses. For more details, visit https://blockleviton.com/cases/clbt. What is this all about? Block & Leviton is investigating whether Cellebrite and certain of its executives may have violated the federal securities laws. In May 2026, Cellebrite's then-CEO told investors that its U.S. federal business was "beginning to accelerate" and pointed to a meaningful pipeline of large government deals ..